The United States Food and Drug Administration (FDA) has rejected the application for menthol refills for the Vuse Vibe and Ciro e-cigarettes. The rejection is a part of the FDA’s efforts to curb youth vaping and prevent the appeal of menthol-flavored e-cigarettes to young people.
Menthol is a popular flavor among youth and young adults, and the FDA has previously banned the sale of all flavored e-cigarette pods, except for tobacco and menthol. The FDA’s decision to reject the application for menthol refills for the Vuse Vibe and Ciro e-cigarettes is in line with their efforts to prevent the appeal of menthol-flavored e-cigarettes to young people.
The FDA’s decision to reject the application is based on the agency’s concerns that the marketing and sale of menthol refills for the Vuse Vibe and Ciro e-cigarettes would appeal to youth and increase their use of e-cigarettes. The FDA also stated that the application did not provide sufficient evidence that the menthol refills would benefit the public health.
This decision is a major blow to the manufacturers of Vuse Vibe and Ciro e-cigarettes, as menthol is a popular flavor among e-cigarette users, and the rejection of the application will likely result in a decrease in sales for these products.
In summary, the FDA has rejected the application for menthol refills for the Vuse Vibe and Ciro e-cigarettes as part of the agency’s efforts to curb youth vaping and prevent the appeal of menthol-flavored e-cigarettes to young people.
The decision is based on the agency’s concerns that the marketing and sale of menthol refills for the Vuse Vibe and Ciro e-cigarettes would appeal to youth and increase their use of e-cigarettes, and that the application did not provide sufficient evidence that the menthol refills would benefit the public health.
0 Comments